Global Continuous Bioprocessing Market by Product (Bioreactors, Cell Culture Media & Reagent, Centrifuges), Process (Downstream Bioprocess, Upstream Bioprocess), Application, Scale of Operation, End-User - Forecast 2024-2030- Product Image

Sale

Global Continuous Bioprocessing Market by Product (Bioreactors, Cell Culture Media & Reagent, Centrifuges), Process (Downstream Bioprocess, Upstream Bioprocess), Application, Scale of Operation, End-User - Forecast 2024-2030

Report
189 Pages
March 2024
Region: Global
360iResearch™
ID: 5012940

UP TO €851EUR$875USD£729GBP OFF until Dec 31^st 2024

The Continuous Bioprocessing Market size was estimated at USD 233.44 million in 2023, USD 282.42 million in 2024, and is expected to grow at a CAGR of 21.30% to reach USD 902.23 million by 2030.

Continuous bioprocessing represents a paradigm shift in the production of biopharmaceutical products, such as vaccines, monoclonal antibodies, or therapeutic proteins. Continuous bioprocessing allows for the uninterrupted flow of materials and products through the production cycle, offering potential improvements in efficiency, quality control, and scalability, unlike traditional batch processing, which processes a fixed volume of products in discrete steps. Pharmaceutical industries are advancing, and government support for the sector is the principal driver of growth for continuous bioprocessing. Increased benefits of over-batch processing & uptake of single-use technology and the continued demand for the production of biopharmaceutical products are spurring the adoption of continuous bioprocessing technologies. In contrast, high equipment costs, operational difficulties, and process change concerns pose a challenge to adopting a continuous bioprocess. In addition, regulatory considerations must be managed, as continuous bioprocessing may necessitate new validation strategies to comply with the stringent standards set by health authorities. However, several market vendors invest in research and development to address many operational challenges in the continuous bioprocessing technologies and further chart to expand the market. Moreover, the adoption of perfusion is associated with single-use equipment, and the development of a continuous bioprocessing approach to stromal cell manufacturing is expected to enhance overall market growth in the coming years significantly.

Regional Insights

In the American region, the adoption of continuous bioprocessing is driven by a strong focus on innovation in biomanufacturing, significant investments in the biotech sector, and a regulatory environment encouraging advanced production techniques. With major pharmaceutical companies and biotech startups striving to achieve more efficient, cost-effective, and scalable manufacturing processes, continuous bioprocessing offers a competitive advantage. Additionally, the presence of a robust technological infrastructure and highly skilled workforce has facilitated the transition from traditional batch processes to continuous approaches in the Americas. Furthermore, in EMEA, high operational costs and stringent regulatory standards have pushed companies to adopt continuous bioprocessing to reduce costs and enhance the quality of biologics. The European pharmaceutical landscape is known for its strong emphasis on innovation and sustainability, which is further reflected in its rapidly growing biosimilar market, where continuous bioprocessing delivers substantial benefits in terms of production agility and speed to market. Additionally, adopting such processes is nascent in the Middle East and Africa. In this region, the continuous bioprocessing is expected to grow by the increasing need for biologics and efforts to localize pharmaceutical production capabilities. The APAC region has seen a surge in adopting continuous bioprocessing due to its rapidly expanding biopharmaceutical sector and the need to compete globally. A growing patient population needs high-quality biologics, increasing investments from players in biotechnology, and supportive government initiatives aiming to boost biomanufacturing capabilities. Several countries have demonstrated significant interest in incorporating continuous processes to accelerate drug development and production timelines, reduce manufacturing footprints, and enable cost savings, all while complying with international quality standards.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Continuous Bioprocessing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Bioprocessing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Continuous Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, 3M Company, Adolf Kühner AG, bbi-biotech GmbH, Belach Bioteknik AB, Bio-Rad Laboratories, Inc., Bionet Servicios Técnicos S.L., Colder Products Company, Danaher Corporation, Esco Aster Pte Ltd., Esco VacciXcell, FiberCell Systems Inc., Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., GEA Group, Getinge AB, Infors AG, Merck KGaA, Repligen Corporation, Sartorius AG, simAbs NV, Suzhou Transcenta Therapeutics Co., Ltd., Thermo Fisher Scientific Inc., Watson-Marlow Fluid Technology Group, and WuXi Biologics Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Continuous Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Bioreactors
- Cell Culture Media & Reagent
- Centrifuges
- Chromatography System
- Filtration Systems
- Incubators & Shakers
Process
- Downstream Bioprocess
- Upstream Bioprocess
Application
- Cell & Gene Therapy
- Monoclonal Antibodies
- Vaccines
Scale of Operation
- Clinical Operations
- Commercial Operations
End-User
- Academic & Research Institutes
- Contract Development & Manufacturing Organizations
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Continuous Bioprocessing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Bioprocessing Market?
What are the technology trends and regulatory frameworks in the Continuous Bioprocessing Market?
What is the market share of the leading vendors in the Continuous Bioprocessing Market?
Which modes and strategic moves are suitable for entering the Continuous Bioprocessing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Continuous Bioprocessing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for biopharmaceuticals & government support for the industry
5.1.1.2. Increased benefits over batch processing & uptake of single-use technology
5.1.1.3. Advent of industry 4.0 & trend towards automation & digitization
5.1.2. Restraints
5.1.2.1. Strict regulations for continuous bioprocessing coupled with high equipment cost
5.1.3. Opportunities
5.1.3.1. Adoption of perfusion associated with single-use equipment
5.1.3.2. Development of a continuous bioprocessing approach to stromal cell manufacturing
5.1.4. Challenges
5.1.4.1. Issues with operational difficulties and process changes
5.2. Market Segmentation Analysis
5.2.1. Product: Growing preference for bioreactors in large-scale production of recombinant proteins
5.2.2. Process: Rising usage of upstream processes owing to progress in terms of efficiency and capacity
5.2.3. Application: Extensive utilization of continuous bioprocessing in the vaccine industry to improve public health
5.2.4. Scale of Operation: Growing application of continuous bioprocessing in the clinical operations
5.2.5. End-User: Significant role of continuous bioprocessing in CDMO as they prioritize flexibility and service offering enhancements for their clients
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Continuous Bioprocessing Market, by Product

6.1. Introduction
6.2. Bioreactors
6.3. Cell Culture Media & Reagent
6.4. Centrifuges
6.5. Chromatography System
6.6. Filtration Systems
6.7. Incubators & Shakers

7. Continuous Bioprocessing Market, by Process

7.1. Introduction
7.2. Downstream Bioprocess
7.3. Upstream Bioprocess

8. Continuous Bioprocessing Market, by Application

8.1. Introduction
8.2. Cell & Gene Therapy
8.3. Monoclonal Antibodies
8.4. Vaccines

9. Continuous Bioprocessing Market, by Scale of Operation

9.1. Introduction
9.2. Clinical Operations
9.3. Commercial Operations

10. Continuous Bioprocessing Market, by End-User

10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Development & Manufacturing Organizations
10.4. Pharmaceutical & Biotechnology Companies

11. Americas Continuous Bioprocessing Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Continuous Bioprocessing Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Continuous Bioprocessing Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. New Product Launch & Enhancement
14.3.1.1. WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale
14.3.1.2. Sartorius and Repligen Launch Integrated Bioreactor System
14.3.2. Investment & Funding
14.3.2.1. 3M To Invest Nearly USD 150 Million To Advance Capabilities In Biopharma Filtration Technology

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. 3D Biotek LLC
15.1.2. 3M Company
15.1.3. Adolf Kühner AG
15.1.4. bbi-biotech GmbH
15.1.5. Belach Bioteknik AB
15.1.6. Bio-Rad Laboratories, Inc.
15.1.7. Bionet Servicios Técnicos S.L.
15.1.8. Colder Products Company
15.1.9. Danaher Corporation
15.1.10. Esco Aster Pte Ltd.
15.1.11. Esco VacciXcell
15.1.12. FiberCell Systems Inc.
15.1.13. Fujifilm Holdings Corporation
15.1.14. GE HealthCare Technologies Inc.
15.1.15. GEA Group
15.1.16. Getinge AB
15.1.17. Infors AG
15.1.18. Merck KGaA
15.1.19. Repligen Corporation
15.1.20. Sartorius AG
15.1.21. simAbs NV
15.1.22. Suzhou Transcenta Therapeutics Co., Ltd.
15.1.23. Thermo Fisher Scientific Inc.
15.1.24. Watson-Marlow Fluid Technology Group
15.1.25. WuXi Biologics Co., Ltd.
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. CONTINUOUS BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS BIOPROCESSING MARKET SIZE, 2023 VS 2030
FIGURE 3. CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONTINUOUS BIOPROCESSING MARKET DYNAMICS
FIGURE 7. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 10. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2030 (%)
FIGURE 14. CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CONTINUOUS BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 13. CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 20. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CLINICAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 44. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 71. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 76. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 162. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 182. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 187. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 236. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. CONTINUOUS BIOPROCESSING MARKET LICENSE & PRICING

Companies Mentioned

3D Biotek LLC
3M Company
Adolf Kühner AG
bbi-biotech GmbH
Belach Bioteknik AB
Bio-Rad Laboratories, Inc.
Bionet Servicios Técnicos S.L.
Colder Products Company
Danaher Corporation
Esco Aster Pte Ltd.
Esco VacciXcell
FiberCell Systems Inc.
Fujifilm Holdings Corporation
GE HealthCare Technologies Inc.
GEA Group
Getinge AB
Infors AG
Merck KGaA
Repligen Corporation
Sartorius AG
simAbs NV
Suzhou Transcenta Therapeutics Co., Ltd.
Thermo Fisher Scientific Inc.
Watson-Marlow Fluid Technology Group
WuXi Biologics Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 282.42 Million
Forecasted Market Value ( USD ) by 2030	$ 902.23 Million
Compound Annual Growth Rate	21.3%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3283EUR$3,374USD£2,812GBP €3648EUR$3,749USD£3,125GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4159EUR$4,274USD£3,562GBP €4621EUR$4,749USD£3,958GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5034EUR$5,174USD£4,313GBP €5594EUR$5,749USD£4,792GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5910EUR$6,074USD£5,063GBP €6567EUR$6,749USD£5,625GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7661EUR$7,874USD£6,563GBP €8513EUR$8,749USD£7,292GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), End-user, and Region - Forecast to 2028

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030

Global Continuous Bioprocessing Market: Focus on Application, Product, Process, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

Global Continuous Bioprocessing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Global Single-use Bioprocessing Market by Function (Cell Culture, Filtration, Mixing), Product (Bioprocess Drums Liners & Accessories, Disposable Mixers, Disposable or Single-Use Bioreactors), Workflow, End-User - Forecast 2024-2030